Key Matters
- Counsel to former senior public official in a federal public corruption matter arising from a long-running investigation. Allegations included racketeering, bribery, and misuse of official authority.
- Conducted internal investigation for a pharmaceutical manufacturer following whistleblower allegations concerning disclosures to federal regulators related to a COVID-19 antibody product. Issues included the accuracy of prior regulatory submissions and potential exposure under federal enforcement statutes.
- Advised participant in the U.S. refined sugar industry in connection with antitrust allegations based on parallel pricing.
- Represented an individual in digital-asset litigation involving allegations arising from token promotion and decentralized governance.
- Represented a compounding pharmacy in a federal investigation involving alleged healthcare program fraud and kickback arrangements.
